oxazoles has been researched along with Coxsackie Virus Infections in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (8.33) | 18.7374 |
| 1990's | 1 (8.33) | 18.2507 |
| 2000's | 4 (33.33) | 29.6817 |
| 2010's | 4 (33.33) | 24.3611 |
| 2020's | 2 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Honkimaa, A; Hyöty, H; Sioofy-Khojine, AB | 1 |
| Galabov, AS; Stoyanova, A | 1 |
| Galabov, AS; Nikolova, I; Stoyanova, A | 1 |
| Häkkinen, H; Lahtinen, T; Malola, S; Marjomäki, V; Martikainen, M; Permi, P; Salorinne, K | 1 |
| Cheng, XY; Jiang, JD; Kong, LY; Li, YH; Song, DQ; Tang, S; Wang, HQ; Zhang, X | 1 |
| Dimitrov, V; Dobrikov, G; Galabov, AS; Nikolova, I; Philipov, S; Pürstinger, G; Stoyanova, A | 1 |
| Ashkenazi, S; Bauer, S; Gottesman, G; Levi, I; Litmanovitz, I; Sirota, L | 1 |
| Bryant, PA; Curtis, N; Dargaville, PA; Starr, M; Tingay, D | 1 |
| Berg, AK; Frisk, G; Korsgren, O; Olsson, A | 1 |
| Groarke, JM; Pevear, DC; Seipel, ME; Tull, TM | 1 |
| Schiff, GM; Sherwood, JR | 1 |
| Diana, GD; Dutko, FJ; McKinlay, MA; Otto, MJ; Rogge, MC; Woods, MG | 1 |
2 trial(s) available for oxazoles and Coxsackie Virus Infections
| Article | Year |
|---|---|
Severe Coxsackie virus B infection in preterm newborns treated with pleconaril.
Topics: Antiviral Agents; Coxsackievirus Infections; Diseases in Twins; Enterovirus B, Human; Female; Humans; Infant, Newborn; Infant, Premature; Oxadiazoles; Oxazoles | 2002 |
Clinical activity of pleconaril in an experimentally induced coxsackievirus A21 respiratory infection.
Topics: Adolescent; Adult; Antibodies, Viral; Antiviral Agents; Coxsackievirus Infections; Enterovirus; Female; Humans; Male; Middle Aged; Mucus; Nose; Oxadiazoles; Oxazoles; Respiratory Tract Infections; Virus Shedding | 2000 |
10 other study(ies) available for oxazoles and Coxsackie Virus Infections
| Article | Year |
|---|---|
A preclinical assessment to repurpose drugs to target type 1 diabetes-associated type B coxsackieviruses.
Topics: A549 Cells; Amides; Antiviral Agents; Azithromycin; Benzimidazoles; Coxsackievirus Infections; Diabetes Mellitus, Type 1; Drug Repositioning; Enterovirus B, Human; Fluoxetine; Guanidine; Humans; Immunoglobulin G; Lovastatin; Oxadiazoles; Oxazoles; Oximes; Pyrazines; Ribavirin; Sulfonamides | 2020 |
Effect of Consecutive Alternating Administration of a Triple Combination of Anti-Enteroviral Compounds in Mice Infected with Coxsackievirus B3.
Topics: Animals; Antiviral Agents; Apomorphine; Cell Line; Coxsackievirus Infections; Disease Models, Animal; Drug Resistance, Viral; Drug Synergism; Drug Therapy, Combination; Enterovirus B, Human; Humans; Mice; Nitriles; Oxadiazoles; Oxazoles; Virus Replication | 2020 |
Effect of consecutive alternating administration (CAA) of a triple anti-enteroviral combination on Coxsackievirus B1 neuroinfection in mice.
Topics: Animals; Antiviral Agents; Apomorphine; Brain; Central Nervous System Infections; Coxsackievirus Infections; Disease Models, Animal; Drug Resistance, Viral; Drug Therapy, Combination; Enterovirus B, Human; Guanidine; Mice, Inbred ICR; Microbial Sensitivity Tests; Oxadiazoles; Oxazoles; Survival Analysis; Treatment Outcome | 2015 |
Hydrophobic pocket targeting probes for enteroviruses.
Topics: Cell Line, Tumor; Coxsackievirus Infections; Enterovirus B, Human; Fluorescent Dyes; Gold; Humans; Hydrophobic and Hydrophilic Interactions; Oxadiazoles; Oxazoles | 2015 |
SAR evolution and discovery of benzenesulfonyl matrinanes as a novel class of potential coxsakievirus inhibitors.
Topics: Animals; Antiviral Agents; Cell Line; Cell Survival; Chlorocebus aethiops; Coxsackievirus Infections; Drug Discovery; Drug Resistance, Viral; Enterovirus; Humans; Isoquinolines; Male; Mice; Oxadiazoles; Oxazoles; RNA, Viral; Serine Endopeptidases; Structure-Activity Relationship; Sulfonamides; Vero Cells; Viral Proteins | 2016 |
Anti-enteroviral triple combination of viral replication inhibitors: activity against coxsackievirus B1 neuroinfection in mice.
Topics: Animals; Antiviral Agents; Apomorphine; Cells, Cultured; Coxsackievirus Infections; Drug Resistance, Viral; Drug Therapy, Combination; Enterovirus B, Human; Humans; Mice; Mice, Inbred ICR; Microbial Sensitivity Tests; Nitriles; Oxadiazoles; Oxazoles; Virus Replication | 2015 |
Neonatal coxsackie B virus infection-a treatable disease?
Topics: Antiviral Agents; Cardiomyopathies; Coxsackievirus Infections; Disseminated Intravascular Coagulation; Enterovirus B, Human; Hepatitis; Humans; Infant; Infant, Newborn; Infant, Premature; Infectious Disease Transmission, Vertical; Meningoencephalitis; Oxadiazoles; Oxazoles; Perinatal Care; Polymerase Chain Reaction; Thrombocytopenia | 2004 |
Antiviral treatment of Coxsackie B virus infection in human pancreatic islets.
Topics: Antiviral Agents; Cells, Cultured; Coxsackievirus Infections; Cytopathogenic Effect, Viral; Diabetes Mellitus, Type 1; Enterovirus B, Human; Humans; Insulin; Islets of Langerhans; Oxadiazoles; Oxazoles | 2007 |
Activity of pleconaril against enteroviruses.
Topics: Animals; Animals, Newborn; Animals, Suckling; Antiviral Agents; Cells, Cultured; Coxsackievirus Infections; Enterovirus; Female; Humans; Male; Mice; Mice, Inbred BALB C; Mice, Inbred ICR; Oxadiazoles; Oxazoles; Serotyping; Virus Replication | 1999 |
In vitro and in vivo activities of WIN 54954, a new broad-spectrum antipicornavirus drug.
Topics: Animals; Animals, Suckling; Antiviral Agents; Coxsackievirus Infections; Culture Media; Echovirus Infections; Female; Isoxazoles; Mice; Mice, Inbred ICR; Oxazoles; Picornaviridae; Rhinovirus; Viral Plaque Assay; Virus Replication | 1989 |